Advertisement|Remove ads.

A critical remark from “The Big Short” investor Michael Burry on Palantir Technologies sent the stock to its steepest drop in two months on Wednesday, even as the broader market climbed. Now, Burry has deleted the posts from X and his Substack – where he wrote “Anthropic is eating Palantir’s lunch” – and is facing mounting scrutiny over his thesis.
Burry is short on Palantir, a position he disclosed last September, and has repeatedly voiced concerns over the company’s business, including alleged inflated accounting and high spending on private jets by its chief executive, Alex Karp.
In the now-deleted posts, he indicated that Palantir might be losing enterprise software market share to Anthropic, which recently disclosed that its average revenue run-rate had climbed to $30 billion from $9 billion in a matter of months.
Of note is a key collaboration between Palantir and Anthropic in the former’s main and widely used defense software. Palantir’s Project Maven integrates Anthropic’s Claude models via its AI Platform (AIP) to analyze defense data and generate intelligence insights within operational workflows.
Burry’s comments sparked a huge debate among traders on Stocktwits, with many arguing that his comparison is flawed and serves only his agenda.
“Burry is trying to cause algos to sell-off based on keywords. He tried (the) same BS in one of his last attempts advocating accounting trickery with the Karp private jet cost crap,” a user said. “Anthropic isn't eating into PLTR, PLTR and anthropic are eating into the human inefficiency and generic software.”
Another wrote: “Anthropic can never displace Palantir. Burry is just desperate.”
The core argument is that Anthropic vs Palantir is not an apples-to-apples comparison. Anthropic builds AI models, while Palantir builds software platforms (AIP, Foundry) that enable large organizations to use those models with their own private data.
In fact, Stocktwits retail sentiment for PLTR flipped to ‘bullish’ early Thursday, from ‘bearish’ the previous day. The stock inched marginally higher in the overnight session. “Any volatile PLTR dips like today…are gifts,” posted a user.
Meanwhile, enterprise customers appear to be hooked on Palantir’s platform. The UK’s National Health Service is planning to embed the company’s technology deeper into hospitals over the coming year, the Financial Times reported, citing comments from a chief scientist at the federal agency.
NHS’s Federated Data Platform, which collates patient information and is largely powered by Palantir’s Foundry software, is delivering “outstanding results” by speeding up surgery and getting patients home quicker, Ming Tang, chief data officer at NHS England, was quoted as saying.
Palantir shares are down 21% year-to-date.
For updates and corrections, email newsroom[at]stocktwits[dot]com.